PTC Therapeutics PTCT Income Tax
Income Tax at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's income tax?
- PTC Therapeutics (PTCT) reported income tax of $347K in Q1 2026.
- How has PTC Therapeutics's income tax changed year-over-year?
- PTC Therapeutics's income tax decreased by 99.5% year-over-year, from $63.27M to $347K.
- What is the long-term trend for PTC Therapeutics's income tax?
- Over 2 years (2021 to 2023), PTC Therapeutics's income tax has grown at a 253.6% compound annual growth rate (CAGR), from $5.56M to -$69.51M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.